VEGF and bFGF Gene Polymorphisms in Patients with Non-Hodgkin's Lymphoma

Table 1

Patients characteristics.

Characteristics	NHL patients (𝑛=78)
Sex
Female	31
Male	47
Age
<60 yrs	51
>60 yrs	27
Ann Arbor stage
I/II	13
III/IV	65
B symptoms
Absent	13
Present	65
Serum LDH
Normal	49
Elevated*	29
Performance status (ECOG)
<2	24
≥2	54
Number of extranodal sites
<2	55
≥2	23
Serum β2-microglobulin
Normal	20
Elevated^†	35
Unknown	23
IPI risk groups
Low/intermediate low (1, 2)	40
Intermediate high/high (3, 4)	38
Histological aggressiveness
Indolent	40
Follicular	17
Small lymphocytic	15
Other B cells	8
Aggressive	38
Diffuse large B-cell lymphoma	28
Mantle	5
Lymphoblastic	2
Peripheral T cell	3
Survival
Dead	47
Alive	31
Response to treatment
Complete remission	35
Partial remission	30
No response	13

NHL: non-Hodgkin’s lymphoma; LDH: serum lactate dehydrogenase; ECOG: Eastern Cooperative Oncology Group; IPI: International Prognostic Index.
*>480 U/L; †>1.80 mg/L.